Form 4: Calix Director Kevin Peters Reports Stock Option Grant

Kevin Peters, a director at Calix, Inc., reported the acquisition of stock options exercisable for 12,262 shares of common stock on May 9, 2024.

Summary

• This Form 4 filing reports a transaction by Kevin Robert Peters, a director of Calix, Inc.
• On May 9, 2024, Peters acquired stock options to purchase 12,262 shares of Calix common stock at an exercise price of $30.07.
• The options vest and become exercisable on the earlier of May 9, 2025, or the day before the next annual meeting of stockholders.
• Following the transaction, Peters directly owns options for 12,262 shares.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing regarding stock option grants, which is generally neutral. It reflects standard compensation practices.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Stock option grants are a common form of executive compensation in the technology industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in the tech sector.
• The vesting schedule of one year is fairly typical, encouraging long-term commitment.
• Comparing the size of the grant to similar companies would require further analysis of Calix's compensation policies and peer group data.

Stakeholder Impact

• The stock option grant could incentivize the director to improve company performance, benefiting shareholders.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates